- Research article
- Open Access
Variation of perioperative plasma mitochondrial DNA correlate with peak inflammatory cytokines caused by cardiac surgery with cardiopulmonary bypass
Journal of Cardiothoracic Surgery volume 10, Article number: 85 (2015)
Cardiac surgery with cardiopulmonary bypass (CPB) may cause inflammatory responses, which can deteriorate the outcomes. Inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6,–8 and -10, can act as both the effector and the predictor for post-operative inflammatory responses. Plasma mitochondrial DNA (mtDNA) was found as a pro-inflammatory agent recently, which was released when cells were insulted.
In the present study, we included 38 patients undergoing coronary artery bypass graft (CABG) to analyze their perioperative plasma mtDNA and levels of inflammatory cytokines. Blood samples were collected before aortic cross-clamping (T1), at the end of CPB (T2), 6 h post-CPB (T3), 12 h post-CPB (T4), and 24 h post-CPB (T5). Rt-PCR and specific ELISA kits were used to quantify the plasma mtDNA and inflammatory cytokines, respectively. Bivariate correlations analysis was used to check the correlations between plasma mtDNA and inflammatory cytokines respectively.
Results shown that plasma mtDNA elevated significantly at T2 and peaked at T4. Furthermore, plasma TNF-α, IL-6 and IL-8 levels significantly increased at T2 and peaked at T3 while IL-10 elevated and peaked at T2. Bivariate correlations analysis showed that the peak plasma mtDNA were positively correlated with the peak TNF-α (r = 0.677, P < 0.001), the peak IL-6 (r = 0.706, P < 0.001), the peak IL-8 (r = 0.584, P < 0.001) and the peak IL-10 (r = 0.565, P < 0.001).
We found that plasma mtDNA might play a key role in CPB-induced post-operative inflammatory responses.
The first case of extracorporeal circulation (ECC) was reported by Gibbon JH in 1954 to successfully save a patient with atrial septal defect (ASD) . In 1955, Kirklin et al. combined the ECC with the oxygenator in intra-cardiac surgery and since then, the technique of cardiopulmonary bypass (CPB) was developed to be the key process in modern cardiothoracic surgery . While the CPB helping to bypass circulation out of the heart and lung during the operation, the abnormal status of circulation and the ischemia/reperfusion injury (I/R injury) may cause inflammatory responses . It is well known that most of postoperative complications are related to the systemic inflammatory response syndrome (SIRS) and many studies demonstrated that inflammatory mediators, like tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-8 and IL-10, increased significantly after cardiac surgery with CPB [4–7]. Although many anti-inflammatory agents and coated circuits were investigated to reduce the inflammatory responses after CPB, we still need a more efficient way to eliminate the inflammatory responses and then protect the secondary damage to the heart and other organs [8, 9].
Human mitochondrial DNA (mtDNA) consist of 16569 nucleotide bases and take responsible for encoding 13 polypeptides of the electron transport chain, 22 transfer RNAs, and 2 ribosomal RNAs . mtDNA was released into circulation and trigger inflammatory responses when cells were dealing with harmful insults . With the pro-inflammatory CpG motif, mtDNA acts as a damage-associated molecular patterns (DAMPs) . It is documented that mtDNA played a pro-inflammatory role in several diseases. Plasma mtDNA was elevated remarkably in trauma patients, comparing to volunteers . Recently, a study based on multiple cohorts showed that mtDNA can improve risk prediction and there is a tight relationship between elevated plasma mtDNA level and 28-day mortality .
Given the pro-inflammatory features of mtDNA and series of inflammatory responses after CPB, we hypothesized that mtDNA may act as a pro-inflammatory factor after cardiac surgery with CPB and play a key role in post-CPB inflammatory responses with other inflammatory factors, such as TNF-α, IL-6, IL-8 and IL-10.
Thirty-eight patients were included from January 2014 to August 2014, who were admitted to the Department of Cardiovascular Surgery, West China Hospital, requiring coronary artery bypass graft (CABG). Medical histories of endocarditis, diabetes, hypertension, neurological diseases, psychiatric diseases, infectious diseases, and post-surgical acute renal failure and low cardiac output syndrome were designed as the excluding criteria. All patients had normal function of kidney, liver and lung prior to surgery. Informed consents were signed by every patients. CABG with CPB and postoperative standard care in cardiac intensive care unit (CICU) were performed successfully for all patients. The study was conducted following the Declaration of Helsinki and registered in the research committee at the Sichuan University.
Blood samples collection
Blood samples were collected in EDTA-coated blood collection tube before aortic cross-clamping (T1), at the end of CPB (T2), 6 h post-CPB (T3), 12 h post-CPB (T4), 24 h post-CPB (T5). The whole blood was centrifuged at 1000 rpm/min for 15 min at 4° and subsequently supernatant was collected as plasma. Samples of plasma were stored in -80° freezer and ready for rt-PCR and ELISA.
DNA isolation and rt-PCR for mtDNA
The whole plasma DNA was isolated from plasma using the DNeasy Blood and Tissue Kit (#69504, Qiagen). Briefly, 50 μL plasma samples were added to50 μL phosphate buffered saline (PBS) and then centrifuged at 16000 g for 15 min at 4°. 90 μL of supernatant were kept for the next procedures. The rest procedures were performed according to the manufacture’s protocol. At the last step, 200 μL elution buffer were added to resolve the plasma DNA.
Plasma mtDNA levels were measured by SYBR-green dye-based rt-PCR assay using a PRISM 7300 sequence detection system. The primer sequences were human NADH dehydrogenase 1 gene (mtDNA): forward CGAGCAGTAGCCCAAACAAT, reverse TGTGATAAGGGTGGAGAGGTT. Plasmid DNA with complementary DNA sequence for human mtDNA was obtained from ORIGENE (SC101172, USA). Concentration of plasma mtDNA were converted to copy number via a DNA copy number calculator (http://cels.uri.edu/gsc/cndna.html; University of Rhode Island Genomics and Sequencing Center). Plasmid DNA were diluted in 10-fold serial dilutions and measured as standard curve .
All samples were measured with standards at the same time. Plasma mtDNA levels were shown in copies per microliter of plasma according to the following formula:
where c is the concentration of plasma mtDNA (copies/μL); Q means the quantity of DNA measured by rt-PCR; VDNA means the total volume of plasma DNA solution obtained from the extraction, 200 μL in this study; VPCR means the volume of plasma DNA solution for rt-PCR, 1 μL in this study; Vext means the volume of plasma used for the extraction, 50 μL in this study.
Measurement of cytokines
Plasma TNF-α, IL-6, IL-8 and IL-10 were measured by enzyme-linked immunosorbent assay (ELISA) kit (Solarbio, China). All procedures were followed standard protocols (included in the ELISA kits). Spectrophotometry was used to detect the intensity of the transmitted light. Data was expressed in picogram per mL.
All descriptive data were shown as mean ± standard error of the mean (SEM). Multiple comparisons were analyzed by one-way ANOVA followed by Bonferroni’s test. The Pearson correlation coefficient test were performed. P < 0.05 was considered to statistically significant.
Patient basic characteristics, surgery information and laboratory data were presented in Table 1. 38 patients were included and performed CABG successfully. During the surgery, the average of aortic cross-clamping time is (68 ± 21) min and the average CPB time is (96 ± 27) min. On admission, we collected the baseline levels of serum creatinine, hemoglobin, total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides (TG), glucose and hematocrit (Hct).
Changes of perioperative plasma mtDNA levels
Plasma mtDNA levels at different time points were measured by rt-PCR. Given that much fluid was administered during the surgery, all plasma mtDNA results were corrected based on the Hct measured on admission. As shown in Fig. 1, plasma mtDNA levels elevated significantly after the end of CPB (T2) and peaked at 12 h post-CPB (T4), which decreased remarkably at 24 h post-CPB (P < 0.05).
Changes of perioperative cytokines levels
TNF-α, IL-6, IL-8 and IL-10 were measured by specific ELISA kits at the same time points. All concentrations were corrected based on the Hct measured on admission. Merged curves of these four cytokines were presented in Fig. 2. We found that all these cytokines but IL-6 began to increase significantly after T2 (P < 0.05). However, the highest concentrations of TNF-α and IL-8 appeared at T3, while IL-10 climbed the peak value at T2 (P < 0.05). Concentrations of IL-6 didn’t demonstrate a significant different at T2 comparing with T1 (P > 0.05). Interestingly, it peaked dramatically at T3 and then decreased gradually (P < 0.05).
Correlations between plasma mtDNA and cytokines
Bivariate correlations analysis were used to study the correlation between peak plasma mtDNA levels and peak cytokines levels. Positively correlation between the peak plasma mtDNA and the peak TNF-α (r = 0.697, P < 0.001), the peak IL-6 (r = 0.710, P < 0.001), the peak IL-8 (r = 0.527, P < 0.001) and the peak IL-10 (r = 0.535, P < 0.001) were confirmed and presented in Fig. 3.
Our study demonstrated that plasma mtDNA was released during cardiac surgery with CPB. We found the peak value of plasma mtDNA was shown up at 12 h post-CPB through five time points tracking analysis. Meanwhile, we confirmed releasing patterns of inflammatory cytokines, such as TNF-α, IL-6, IL-8 and IL-10, after cardiac surgery with CPB. We revealed a significantly and positively correlation between the peak plasma mtDNA and peak cytokines levels.
CPB-induced systemic inflammatory response syndrome was affected by many factors, such as the contact between blood and foreign surface of the extracorporeal circuits, hypothermia, reduction of pulmonary blood flow, direct surgical damage to the heart and endotoxemia . It is studied that excessive inflammatory responses might delay the recovery and attenuate hospital outcomes . As many studies reported, post-operative inflammatory responses were almost happened in every cardiac surgery with CPB, characterized with elevated inflammatory cytokines [6, 17]. In addition, levels of TNF-α, IL-6, IL-8 and IL-10, well-known inflammatory cytokines, represented the severity of inflammatory responses. Dr. Mei YQ et al found that concentrations of plasma IL-6 and IL-8 might be able to evaluate the severity of SIRS after CABG and establish the prognosis . In the present study, we measured inflammatory cytokine levels after CABG with CPB. We found that all these inflammatory cytokines increased significantly after surgery with CPB, which apparently demonstrated that post-operative inflammatory responses occurred. Except for IL-10, which peaking at the end of CPB, all other cytokines peaked at 6 h post-CPB and levels of IL-8 dropped dramatically after peak time while others decreased gradually. Given that CPB-induced I/R condition may cause inflammatory responses , we suggest that IL-10 may act as the factor indicating direct damage-caused inflammatory responses while TNF-α, IL-6, IL-8 may represent I/R injury-induced inflammatory responses.
It is well studied that mtDNA was released after trauma surgery and the release of mtDNA happened in a cell necrosis-independent way. Additionally, the study also revealed that levels of plasma mtDNA were positively correlation with the invasiveness and the complexation of surgery . As a pro-inflammatory agent, mtDNA was studied in many different fields and was confirmed that it can cause inflammatory responses [21–23]. Dr. Zhang Q et al. revealed that circulating mtDNA, a kind of mitochondrial damage-associated molecular patterns, can cause inflammatory responses and create a sepsis-like state . In our study, after CABG with CPB, we found that plasma mtDNA levels elevated after the end of CPB and climbed to the peak value at 12 h post-CPB. And then it decreased gradually but still higher than the baseline level. It is reported that mtDNA was continuously released for at least five days after surgery . As mentioned above, CPB, act as an I/R condition, can cause inflammatory responses. Combing with our result, plasma mtDNA elevation might indicate I/R injury-induced inflammatory responses. After the end of CPB, post-ischemia reperfusion caused secondary damage to the heart and late-peaked plasma mtDNA may indicate this secondary I/R injury-induced damage.
It is studied that plasma mtDNA can be a promising predictor for ICU stay and 28-day mortality . In our study, the bivariate correlations analysis demonstrated a surprising positively correlation between the peak plasma mtDNA and the peak inflammatory cytokines. It is well known that excessive production of inflammatory cytokines may be a predictor for outcomes in different diseases and treatments [24, 25]. Considering that positively correlation between plasma mtDNA and inflammatory cytokines, we suggested that mtDNA might be involved in the progression of post-operative inflammatory responses.
Our study found that release of mtDNA after cardiac surgery with CPB and positively correlation between plasma mtDNA and inflammatory cytokines, suggesting that mtDNA may play an important role in inflammatory responses after CPB. Our data strongly recommended a new insightful point at attenuating post-operative inflammation, which need further studies to illustrate more details about mtDNA-relative mechanism and effects. Additionally, considering that peak time of plasma mtDNA was 12 h post-CPB, later than other inflammatory cytokines, we need further studies to figure out the interaction between mtDNA and other inflammatory cytokines.
Gibbon Jr JH. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954;37(3):171–85. passim.
Kirklin JW, Dushane JW, Patrick RT, Donald DE, Hetzel PS, Harshbarger HG, et al. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (gibbon type): report of eight cases. Proc Staff Meet Mayo Clin. 1955;30(10):201–6.
Zhang Z, Wu Y, Zhao Y, Xiao X, Liu J, Zhou X. Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass. Exp Ther Med. 2013;5(5):1523–7. doi:10.3892/etm.2013.1026.
Caputo M, Mokhtari A, Miceli A, Ghorbel MT, Angelini GD, Parry AJ, et al. Controlled reoxygenation during cardiopulmonary bypass decreases markers of organ damage, inflammation, and oxidative stress in single-ventricle patients undergoing pediatric heart surgery. J Thorac Cardiovasc Surg. 2014;148(3):792–801. doi:10.1016/j.jtcvs.2014.06.001. 3; discussion 0–1.
Samankatiwat P, Samartzis I, Lertsithichai P, Stefanou D, Punjabi PP, Taylor KM, et al. Leucocyte depletion in cardiopulmonary bypass: a comparison of four strategies. Perfusion. 2003;18(2):95–105.
Serrano Jr CV, Souza JA, Lopes NH, Fernandes JL, Nicolau JC, Blotta MH, et al. Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: a prospective randomized study. J Crit Care. 2010;25(2):305–12. doi:10.1016/j.jcrc.2009.06.009.
Mahle WT, Matthews E, Kanter KR, Kogon BE, Hamrick SE, Strickland MJ. Inflammatory response after neonatal cardiac surgery and its relationship to clinical outcomes. Ann Thorac Surg. 2014;97(3):950–6. doi:10.1016/j.athoracsur.2013.10.069.
De Amorim CG, Malbouisson LM, da Silva Jr FC, Fiorelli AI, Murakami CK, Carmona MJ. Leukocyte depletion during CPB: effects on inflammation and lung function. Inflammation. 2014;37(1):196–204. doi:10.1007/s10753-013-9730-z.
Paparella D, Scrascia G, Rotunno C, Marraudino N, Guida P, De Palo M, et al. A biocompatible cardiopulmonary bypass strategy to reduce hemostatic and inflammatory alterations: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2012;26(4):557–62. doi:10.1053/j.jvca.2012.04.010.
Wallace DC. Mitochondrial DNA, in aging and disease. Sci Am. 1997;277(2):40–7.
Mittra I, Nair NK, Mishra PK. Nucleic acids in circulation: are they harmful to the host? J Biosci. 2012;37(2):301–12.
Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, Li H, et al. Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One. 2013;8(3), e59989. doi:10.1371/journal.pone.0059989.
Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104–7. doi:10.1038/nature08780.
Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013;10(12):e1001577. doi:10.1371/journal.pmed.1001577. discussion e.
Kapitein B, van Saet A-W, Golab HD, de Hoog M, de Wildt S, Tibboel D, et al. Does Pharmacotherapy Influence the Inflammatory Responses During Cardiopulmonary Bypass in Children? J Cardiovasc Pharmacol. 2014;64(2):191–7. doi:10.1097/fjc.0000000000000098.
Onorati F, Rubino AS, Nucera S, Foti D, Sica V, Santini F, et al. Off-pump coronary artery bypass surgery versus standard linear or pulsatile cardiopulmonary bypass: endothelial activation and inflammatory response. Eur J Cardiothorac Surg. 2010;37(4):897–904. doi:10.1016/j.ejcts.2009.11.010.
Berger MM, Delodder F, Liaudet L, Tozzi P, Schlaepfer J, Chiolero RL, et al. Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial. Am J Clin Nutr. 2013;97(2):246–54. doi:10.3945/ajcn.112.046573.
Mei YQ, Ji Q, Liu H, Wang X, Feng J, Long C, et al. Study on the relationship of APACHE III and levels of cytokines in patients with systemic inflammatory response syndrome after coronary artery bypass grafting. Biol Pharm Bull. 2007;30(3):410–4.
Bourbon A, Vionnet M, Leprince P, Vaissier E, Copeland J, McDonagh P, et al. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. Eur J Cardiothorac Surg. 2004;26(5):932–8. doi:10.1016/j.ejcts.2004.07.044.
McIlroy DJ, Bigland M, White AE, Hardy BM, Lott N, Smith DW, et al. Cell necrosis-independent sustained mitochondrial and nuclear DNA release following trauma surgery. The J Trauma Acute Care Surg. 2015;78(2):282–8. doi:10.1097/TA.0000000000000519.
Cao H, Ye H, Sun Z, Shen X, Song Z, Wu X, et al. Circulatory mitochondrial DNA is a pro-inflammatory agent in maintenance hemodialysis patients. PLoS One. 2014;9(12), e113179. doi:10.1371/journal.pone.0113179.
Wilkins HM, Carl SM, Weber SG, Ramanujan SA, Festoff BW, Linseman DA, et al. Mitochondrial lysates induce inflammation and Alzheimer’s disease-relevant changes in microglial and neuronal cells. J Alzheimer’s Dis: JAD. 2015;45(1):305–18. doi:10.3233/JAD-142334.
Kim YS, Kwak JW, Lee KE, Cho HS, Lim SJ, Kim KS, et al. Can mitochondrial dysfunction be a predictive factor for oxidative stress in patients with obstructive sleep apnea? Antioxid Redox Signal. 2014;21(9):1285–8. doi:10.1089/ars.2014.5955.
Drapalova J, Kopecky P, Bartlova M, Lacinova Z, Novak D, Maruna P, et al. The influence of deep hypothermia on inflammatory status, tissue hypoxia and endocrine function of adipose tissue during cardiac surgery. Cryobiology. 2014;68(2):269–75. doi:10.1016/j.cryobiol.2014.02.007.
Liao C, Yu Z, Guo W, Liu Q, Wu Y, Li Y, et al. Prognostic value of circulating inflammatory factors in non-small cell lung cancer: a systematic review and meta-analysis. Cancer Biomark. 2014;14(6):469–81. doi:10.3233/CBM-140423.
The authors declare that they have no competing interests.
CQ carried out the molecular study and drafted the manuscript. RL carried out the molecular study, ELISA tests and drafted the manuscript. JG carried out the statistical study and collected clinic data. YL and HQ collected and analyzed clinic data. YS supervised all study and made the literature review. WM supervised all study and made the critical review. All authors read and approved the final manuscript.
This study was financially supported by the National Natural Science Foundation of China (Grant No. 81170288).
Chaoyi Qin and Ruiqi Liu contributed equally to this work.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Qin, C., Liu, R., Gu, J. et al. Variation of perioperative plasma mitochondrial DNA correlate with peak inflammatory cytokines caused by cardiac surgery with cardiopulmonary bypass. J Cardiothorac Surg 10, 85 (2015). https://doi.org/10.1186/s13019-015-0298-6
- Cardiopulmonary bypass
- Mitochondrial DNA
- Inflammatory cytokine